Meldungen zum Thema Medizin, Gesundheit
- Sprache:
- Medien:
- Zeitraum:
- Zeitraum:Gesamt
- mehr
Technische Universität München
On the trail of the genetic code - Overlapping gene found in SARS-CoV-2
Corporate Communications Center phone: +49 8161 5403 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36345/ NEWS RELEASE On the trail of the genetic code Overlapping gene found in SARS-CoV-2 Viruses are infectious organic structures that spread by transmission and can only multiply within a ...
mehr- 5
Commemorative publication for the 25th anniversary of the IZB presents 70 profiles and visions of successful biotech start-ups
Ein Dokumentmehr nal von minden plans to produce 80 million rapid corona tests per month
mehr- 2
German MECOTEC Group launches one-stop-solution for deep-freeze, transport, storage and distribution for COVID-19-Vaccines with its first Mobile Hybrid Container
mehr Swiss Rockets AG announces the founding of ROCKETVAX for the development of a next-generation SARS-CoV-2 vaccine
mehr
- 2
BLOGPOST: Monthly motivation: On minimizing unhappiness
mehr European Commission launches EUR 8 million Next-Generation IoT environments project amid Covid-19 pandemic
mehrTechnische Universität München
Immune response: memory T cells are formed earlier than previously thought
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 22562 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36297/ NEWS RELEASE How the immune system remembers viruses Immune response: memory T cells are formed earlier than previously thought For a person to ...
mehrNew: Combined rapid test for Covid-19 and influenza
mehrEvoBiotiX collaborates with Boehringer Ingelheim and the University of Salzburg on naturally derived Extracellular Vesicles (EVs)
Salzburg/Melide(CH) (ots) - Swiss Biotech EvoBiotiX SA today announced a multi-year collaboration with Boehringer Ingelheim in the field of naturally derived EVs. A significant part of this program will fund research of the drug delivery potential of naturally derived EVs in the group of Prof. Meisner-Kober at the ...
mehrBioplastics successfully meet all EU safety standards
Berlin (ots) - Products made from bio-based plastics must undergo the same testing procedures as conventional plastic products to access the market of the European Union (EU). Thereby a health risk for consumers is excluded. Plastics intended to be certified as biodegradable or compostable require additional tests. "Products made of bioplastics thus pass even more tests than conventional plastic products," explains Hasso ...
mehr
Euroclear Holding, Euroclear Investments, Euroclear SA/NV
Euroclear Business and Financial update - Q3 2020
Brussels (ots/PRNewswire) - Financial Highlights - Year-to-date (Q3 YTD) 2020 revenues down 3% year-on-year, to EUR 1057 million. - Q3 YTD Business Income increased 12% to EUR 951 million, driven by favourable market conditions and implementation of strategic initiatives Q3 YTD Banking and Other Income decreased 55% to EUR 106 million as a result of interest rate cuts - Q3 YTD Operating costs up 3% to EUR 637 million, in ...
mehrDeutsche Bundesstiftung Umwelt (DBU)
German President symbolically presents German Environmental Award via video message / "Taking the climate crisis seriously despite the COVID-19 pandemic "
Hannover/Osnabrück (ots) - Today (25 October 2020), the German Federal Environmental Foundation's German Environmental Award, which has a remuneration of EUR 500,000, is being presented for the 28th time at the HCC Hannover Congress Centrum. In the midst of the COVID-19 pandemic, German President Frank-Walter ...
mehrNew Covid-19 antigen test: Fast and reliable results in just 15 minutes
mehr- 2
Proteintech Acquires ChromoTek, Expanding its Next Generation Antibody Tools
Ein Dokumentmehr Technische Universität München
Coronavirus: door opener facilates cell entry
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 22562 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36263/ NEWS RELEASE How the virus enters the cell Coronavirus: Neuropilin-1 could open the door to the inside of the cell The protein neuropilin-1 facilitates SARS CoV-2 cell entry. A research team including ...
mehrBrenntag Polymers supports BLUE SAFETY in the development of an innovative bottle system for dental units
Ein Dokumentmehr
Technische Universität München
Fighting corona with machine learning
Corporate Communications Center phone: +49 8161 5403 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36254/ NEWS RELEASE The Bavarian Research Foundation is funding five TUM-research projects on Covid-19 Fighting corona with machine learning The Technical University of Munich (TUM) is starting five new research projects that focus on the ...
mehrTechnische Universität München
An alternative to animal experiments - New applications for organoids from human intestinal tissue
Corporate Communications Center phone: +49 8161 5403 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36252/ Images for journalists: https://mediatum.ub.tum.de/1576619 NEWS RELEASE New applications for organoids from human intestinal ...
mehrRegulatory breakthrough for BrainRepair UG start-up - Stem cell treatment for newborns /EMA Orphan Drug Designation is followed by agreement on Paediatric Investigation Plan
mehrRevolutionary face mask can prevent cross-contamination
mehrEUROEXPO Messe- und Kongress GmbH
3Precautionary Postponement of LogiMAT 2021 | New Date: June 22-24, 2021
Ein DokumentmehrFinnish coronavirus tracing app Koronavilkku reaches 2 million downloads
Helsinki (ots) - The Finnish Koronavilkku ('Corona Blinker') application, which helps to break chains of coronavirus infection, has already been downloaded over 2 million times. The milestone of 2 million downloads - 37 % of the population - was reached two weeks after the application became available for download in app stores. 'We all now have a genuine opportunity ...
mehr
UMIT - The Health & Life Sciences University
University UMIT TIROL publishes the first population model to evaluate benefits and harms of universal salt iodization
Hall in Tirol (ots) - An article recently published by Schaffner and colleagues in the medical journal "Thyroid" summarizes the results of a decision-analytic population modeling study evaluating the benefits and harms of universal salt iodization. Iodine is a micronutrient that is essential for the production of ...
mehrSysmex Inostics' Liquid Biopsy Testing Benefits Metastatic Pancreatic Cancer Patient Management
Baltimore, MD (ots) - Sysmex Inostics, Inc., a global leader and pioneer in blood-based circulating cell-free tumor DNA (ctDNA) analysis for oncology, today announces the publication of a clinical study investigating the utility of cfDNA-based markers using the highly sensitive OncoBEAM RAS assay, an enhanced ...
mehr
12IFA 2020 Special Edition - For the first time since the start of the Corona crisis, a global leading trade fair for consumer electronics will be opening its doors
mehrTechnische Universität München
Finding cortisone alternatives with fewer side effects
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 8161 5403 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/die-tum/aktuelles/pressemitteilungen/details/36207/ Images for journalists: https://mediatum.ub.tum.de/1559845 NEWS RELEASE DNA binding is essential for effectiveness of steroids Finding cortisone alternatives with fewer side effects Many people use ...
mehrSysmex Inostics' OncoBEAMTM RAS CRC testing supports clinical outcome improvements for metastatic colorectal cancer patients rechallenged with anti-EGFR therapy
Baltimore, MD (ots) - Sysmex Inostics, Inc., a global leader and pioneer in blood-based circulating tumor DNA (ctDNA) analysis for oncology, today announces the publication of a clinical study evaluating RAS mutation status in circulating tumor DNA (ctDNA) of colorectal cancer (CRC) patients undergoing anti-EGFR ...
mehrEffectiveness and efficiency of targeted intra-operative single dose radiotherapy for breast cancer patients confirmed
Jena, Germany (ots) - New long-term results from the international TARGIT-A breast cancer study, based on ZEISS technology, have been published [1] Use of targeted intra-operative radiotherapy (TARGIT), as a single dose - with ZEISS INTRABEAM - directly after removal of a tumor, confirmed as non-inferior, when ...
mehr